THURSDAY, July 15 (HealthDay News) -- Use of ß-methyl-p-[123I]-iodophenyl-pentadecanoic acid (BMIPP) data in addition to initially available information can help with the early diagnosis of acute coronary syndromes (ACS), according to research published in the July 20 issue of the Journal of the American College of Cardiology.
